Trial Profile
Investigator Initiated Pilot Study of Microarray Directed Therapy for Diffuse Large B-Cell Lymphoma Using Genasense With CHOP-R.
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 27 Oct 2023
Price :
$35
*
At a glance
- Drugs Oblimersen (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Pharmacogenomic; Therapeutic Use
- 12 Oct 2012 Planned End Date changed from 1 Dec 2013 to 1 Oct 2022 as reported by ClinicalTrials.gov record.
- 12 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 02 Jun 2010 Additional trial centre, investigator identified as reported by ClinicalTrials.gov.